These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22130540)

  • 21. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
    Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
    J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets.
    Min JY; Chen GL; Santos C; Lamirande EW; Matsuoka Y; Subbarao K
    Virology; 2010 Dec; 408(1):128-133. PubMed ID: 20926110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
    Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
    PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
    Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
    PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2018 Aug; 36(33):5097-5103. PubMed ID: 30007825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.
    Yu X; Tsibane T; McGraw PA; House FS; Keefer CJ; Hicar MD; Tumpey TM; Pappas C; Perrone LA; Martinez O; Stevens J; Wilson IA; Aguilar PV; Altschuler EL; Basler CF; Crowe JE
    Nature; 2008 Sep; 455(7212):532-6. PubMed ID: 18716625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.
    Wei CJ; Boyington JC; Dai K; Houser KV; Pearce MB; Kong WP; Yang ZY; Tumpey TM; Nabel GJ
    Sci Transl Med; 2010 Mar; 2(24):24ra21. PubMed ID: 20375007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
    Powell TJ; Rijal P; McEwen-Smith RM; Byun H; Hardwick M; Schimanski LM; Huang KA; Daniels RS; Townsend ARM
    J Gen Virol; 2019 Mar; 100(3):431-445. PubMed ID: 30714896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.
    Wrammert J; Koutsonanos D; Li GM; Edupuganti S; Sui J; Morrissey M; McCausland M; Skountzou I; Hornig M; Lipkin WI; Mehta A; Razavi B; Del Rio C; Zheng NY; Lee JH; Huang M; Ali Z; Kaur K; Andrews S; Amara RR; Wang Y; Das SR; O'Donnell CD; Yewdell JW; Subbarao K; Marasco WA; Mulligan MJ; Compans R; Ahmed R; Wilson PC
    J Exp Med; 2011 Jan; 208(1):181-93. PubMed ID: 21220454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.
    Cortina-Ceballos B; Godoy-Lozano EE; Téllez-Sosa J; Ovilla-Muñoz M; Sámano-Sánchez H; Aguilar-Salgado A; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Aparicio-Antonio R; Rodríguez MH; Martínez-Barnetche J
    Genome Med; 2015 Nov; 7():124. PubMed ID: 26608341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
    Alam S; Sant AJ
    J Virol; 2011 Dec; 85(24):13310-21. PubMed ID: 21976658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.
    Hu W; Chen A; Miao Y; Xia S; Ling Z; Xu K; Wang T; Xu Y; Cui J; Wu H; Hu G; Tian L; Wang L; Shu Y; Ma X; Xu B; Zhang J; Lin X; Bian C; Sun B
    Virology; 2013 Jan; 435(2):320-8. PubMed ID: 23084424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model.
    Laurie KL; Carolan LA; Middleton D; Lowther S; Kelso A; Barr IG
    J Infect Dis; 2010 Oct; 202(7):1011-20. PubMed ID: 20715930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.
    Mahallawi WH; Kasbekar AV; McCormick MS; Hoschler K; Temperton N; Leong SC; Beer H; Ferrara F; McNamara PS; Zhang Q
    J Virol; 2013 May; 87(10):5331-9. PubMed ID: 23468498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune history shapes specificity of pandemic H1N1 influenza antibody responses.
    Li Y; Myers JL; Bostick DL; Sullivan CB; Madara J; Linderman SL; Liu Q; Carter DM; Wrammert J; Esposito S; Principi N; Plotkin JB; Ross TM; Ahmed R; Wilson PC; Hensley SE
    J Exp Med; 2013 Jul; 210(8):1493-500. PubMed ID: 23857983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.